These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34533134)

  • 1. Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1.
    Shangguan S; Ehrenberg PK; Geretz A; Yum L; Kundu G; May K; Fourati S; Nganou-Makamdop K; Williams LD; Sawant S; Lewitus E; Pitisuttithum P; Nitayaphan S; Chariyalertsak S; Rerks-Ngarm S; Rolland M; Douek DC; Gilbert P; Tomaras GD; Michael NL; Vasan S; Thomas R
    Elife; 2021 Sep; 10():. PubMed ID: 34533134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials.
    Ehrenberg PK; Shangguan S; Issac B; Alter G; Geretz A; Izumi T; Bryant C; Eller MA; Wegmann F; Apps R; Creegan M; Bolton DL; Sekaly RP; Robb ML; Gramzinski RA; Pau MG; Schuitemaker H; Barouch DH; Michael NL; Thomas R
    Sci Transl Med; 2019 Aug; 11(507):. PubMed ID: 31462510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
    Styles TM; Gangadhara S; Reddy PBJ; Hicks S; LaBranche CC; Montefiori DC; Derdeyn CA; Kozlowski PA; Velu V; Amara RR
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001.
    Costa MR; Pollara J; Edwards RW; Seaman MS; Gorny MK; Montefiori DC; Liao HX; Ferrari G; Lu S; Wang S
    J Virol; 2016 Nov; 90(22):10362-10378. PubMed ID: 27630232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk.
    Neidich SD; Fong Y; Li SS; Geraghty DE; Williamson BD; Young WC; Goodman D; Seaton KE; Shen X; Sawant S; Zhang L; deCamp AC; Blette BS; Shao M; Yates NL; Feely F; Pyo CW; Ferrari G; ; Frank I; Karuna ST; Swann EM; Mascola JR; Graham BS; Hammer SM; Sobieszczyk ME; Corey L; Janes HE; McElrath MJ; Gottardo R; Gilbert PB; Tomaras GD
    J Clin Invest; 2019 Nov; 129(11):4838-4849. PubMed ID: 31589165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines.
    Excler JL; Ake J; Robb ML; Kim JH; Plotkin SA
    Clin Vaccine Immunol; 2014 Aug; 21(8):1023-36. PubMed ID: 24920599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.
    Rolland M; Edlefsen PT; Larsen BB; Tovanabutra S; Sanders-Buell E; Hertz T; deCamp AC; Carrico C; Menis S; Magaret CA; Ahmed H; Juraska M; Chen L; Konopa P; Nariya S; Stoddard JN; Wong K; Zhao H; Deng W; Maust BS; Bose M; Howell S; Bates A; Lazzaro M; O'Sullivan A; Lei E; Bradfield A; Ibitamuno G; Assawadarachai V; O'Connell RJ; deSouza MS; Nitayaphan S; Rerks-Ngarm S; Robb ML; McLellan JS; Georgiev I; Kwong PD; Carlson JM; Michael NL; Schief WR; Gilbert PB; Mullins JI; Kim JH
    Nature; 2012 Oct; 490(7420):417-20. PubMed ID: 22960785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models.
    Pollara J; Jones DI; Huffman T; Edwards RW; Dennis M; Li SH; Jha S; Goodman D; Kumar A; LaBranche CC; Montefiori DC; Fouda GG; Hope TJ; Tomaras GD; Staats HF; Ferrari G; Permar SR
    J Virol; 2019 May; 93(10):. PubMed ID: 30842326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41.
    Duchemin M; Tudor D; Cottignies-Calamarte A; Bomsel M
    Front Immunol; 2020; 11():1141. PubMed ID: 32582208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models.
    Chea LS; Amara RR
    Expert Rev Vaccines; 2017 Oct; 16(10):973-985. PubMed ID: 28838267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprofiling Correlates of Protection Against SHIV Infection in Adjuvanted HIV-1 Pox-Protein Vaccinated Rhesus Macaques.
    Lu P; Guerin DJ; Lin S; Chaudhury S; Ackerman ME; Bolton DL; Wallqvist A
    Front Immunol; 2021; 12():625030. PubMed ID: 34046030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.
    Li SS; Gilbert PB; Carpp LN; Pyo CW; Janes H; Fong Y; Shen X; Neidich SD; Goodman D; deCamp A; Cohen KW; Ferrari G; Hammer SM; Sobieszczyk ME; Mulligan MJ; Buchbinder SP; Keefer MC; DeJesus E; Novak RM; Frank I; McElrath MJ; Tomaras GD; Geraghty DE; Peng X
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31434737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HIV Vaccine Targeting the V2 Region of the HIV Envelope Induces a Highly Durable Polyfunctional Fc-Mediated Antibody Response in Rhesus Macaques.
    Powell RL; Weiss S; Fox A; Liu X; Itri V; Jiang X; Luo CC; Spencer DA; Pandey S; Cheever T; Fuller DH; Totrov M; Hessell AJ; Haigwood NL; Kong XP; Zolla-Pazner S
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
    Pissani F; Schulte B; Eller MA; Schultz BT; Ratto-Kim S; Marovich M; Thongcharoen P; Sriplienchan S; Rerks-Ngarm S; Pitisuttithum P; Esser S; Alter G; Robb ML; Kim JH; Michael NL; Streeck H
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Pro-Inflammatory Signal and T-Cell Activation Associate With Vaccine-Induced Anti-Vaccinia Protective Neutralizing Antibodies.
    Hou J; Wang S; Li D; Carpp LN; Zhang T; Liu Y; Jia M; Peng H; Liu C; Wu H; Huang Y; Shao Y
    Front Immunol; 2021; 12():737487. PubMed ID: 34707608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis.
    Wills S; Hwang KK; Liu P; Dennison SM; Tay MZ; Shen X; Pollara J; Lucas JT; Parks R; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Thomas R; Kim JH; Michael NL; Robb ML; McRaven M; Montefiori DC; Hope TJ; Liao HX; Moody MA; Ferrari G; Haynes BF; Alam SM; Bonsignori M; Tomaras GD
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
    Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
    J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.
    Hessell AJ; Shapiro MB; Powell R; Malherbe DC; McBurney SP; Pandey S; Cheever T; Sutton WF; Kahl C; Park B; Zolla-Pazner S; Haigwood NL
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
    Barouch DH; Tomaka FL; Wegmann F; Stieh DJ; Alter G; Robb ML; Michael NL; Peter L; Nkolola JP; Borducchi EN; Chandrashekar A; Jetton D; Stephenson KE; Li W; Korber B; Tomaras GD; Montefiori DC; Gray G; Frahm N; McElrath MJ; Baden L; Johnson J; Hutter J; Swann E; Karita E; Kibuuka H; Mpendo J; Garrett N; Mngadi K; Chinyenze K; Priddy F; Lazarus E; Laher F; Nitayapan S; Pitisuttithum P; Bart S; Campbell T; Feldman R; Lucksinger G; Borremans C; Callewaert K; Roten R; Sadoff J; Scheppler L; Weijtens M; Feddes-de Boer K; van Manen D; Vreugdenhil J; Zahn R; Lavreys L; Nijs S; Tolboom J; Hendriks J; Euler Z; Pau MG; Schuitemaker H
    Lancet; 2018 Jul; 392(10143):232-243. PubMed ID: 30047376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination.
    Tomalka JA; Pelletier AN; Fourati S; Latif MB; Sharma A; Furr K; Carlson K; Lifton M; Gonzalez A; Wilkinson P; Franchini G; Parks R; Letvin N; Yates N; Seaton K; Tomaras G; Tartaglia J; Robb ML; Michael NL; Koup R; Haynes B; Santra S; Sekaly RP
    Nat Immunol; 2021 Oct; 22(10):1294-1305. PubMed ID: 34556879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.